These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment of Graves' ophthalmopathy by steroid therapy, orbital radiation therapy, plasmapheresis and thyroxine replacement. Yamamoto K; Saito K; Takai T; Yoshida S Endocrinol Jpn; 1982 Aug; 29(4):495-501. PubMed ID: 6897533 [TBL] [Abstract][Full Text] [Related]
24. Orbital radiotherapy for Graves' ophthalmopathy. Bartalena L; Marcocci C; Pinchera A J Clin Endocrinol Metab; 2004 Jan; 89(1):13-4. PubMed ID: 14715819 [No Abstract] [Full Text] [Related]
25. Letter: Orbital radiation in Graves' disease. Rubenzik R Am J Ophthalmol; 1975 May; 79(5):888-9. PubMed ID: 1173740 [No Abstract] [Full Text] [Related]
26. Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy. Wartofsky L J Clin Endocrinol Metab; 1995 Feb; 80(2):347-9. PubMed ID: 7852488 [No Abstract] [Full Text] [Related]
27. Perspective--Part I: the Mayo Orbital Radiotherapy for Graves Ophthalmopathy (ORGO) study: lessons learned. Bartley GB; Gorman CA Ophthalmic Plast Reconstr Surg; 2002 May; 18(3):170-2. PubMed ID: 12021644 [No Abstract] [Full Text] [Related]
28. The use of independent collimation in the treatment of Graves' ophthalmopathy. Snow A Br J Radiol; 1999 Apr; 72(856):389-91. PubMed ID: 10474501 [TBL] [Abstract][Full Text] [Related]
29. Radiation retinopathy after orbital irradiation for Graves' ophthalmopathy. Kinyoun JL; Kalina RE; Brower SA; Mills RP; Johnson RH Arch Ophthalmol; 1984 Oct; 102(10):1473-6. PubMed ID: 6548374 [TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves' ophthalmopathy. Wiersinga WM; Smit T; Schuster-Uittenhoeve AL; van der Gaag R; Koornneef L Ophthalmologica; 1988; 197(2):75-84. PubMed ID: 3186212 [TBL] [Abstract][Full Text] [Related]
32. Orbital radiation for graves ophthalmopathy: a report by the American Academy of Ophthalmology. Bradley EA; Gower EW; Bradley DJ; Meyer DR; Cahill KV; Custer PL; Holck DE; Woog JJ Ophthalmology; 2008 Feb; 115(2):398-409. PubMed ID: 18082885 [TBL] [Abstract][Full Text] [Related]
33. Supervoltage orbital radiotherapy in 36 cases of Graves' disease. Lloyd WC; Leone CR Am J Ophthalmol; 1992 Apr; 113(4):374-80. PubMed ID: 1558110 [TBL] [Abstract][Full Text] [Related]
34. Optic neuropathy following orbital irradiation for Graves' ophthalmopathy: a case report and literature review. Sánchez-Orgaz M; Grabowska A; Royo-Oreja A; Asencio-Durán M; Romero-Martín R; Arbizu-Duralde A Orbit; 2012 Feb; 31(1):30-3. PubMed ID: 22029640 [TBL] [Abstract][Full Text] [Related]
35. Radiotherapy for Graves' ophthalmopathy: results at one year. Gorman CA Thyroid; 2002 Mar; 12(3):251-5. PubMed ID: 11952049 [TBL] [Abstract][Full Text] [Related]